Non-Urothelial Bladder Cancer

Revision as of 09:20, 17 December 2021 by Urology4all (talk | contribs) (Created page with "== Small cell carcinoma of the bladder == * '''Type of neuroendocrine histology''' * '''Should be considered and treated as metastatic disease, even if there is no radiologic evidence of disease outside the bladder''' * In general, primary small cell carcinoma of the bladder is '''very chemosensitive''' * '''Primary mode of therapy is chemoradiation therapy; chemotherapy and radical cystectomy is an option with similar survival''' (5-year CSS 16% chemoradiation vs. 18%...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Small cell carcinoma of the bladder

  • Type of neuroendocrine histology
  • Should be considered and treated as metastatic disease, even if there is no radiologic evidence of disease outside the bladder
  • In general, primary small cell carcinoma of the bladder is very chemosensitive
  • Primary mode of therapy is chemoradiation therapy; chemotherapy and radical cystectomy is an option with similar survival (5-year CSS 16% chemoradiation vs. 18% chemotherapy and radical cystectomy)
  • Primary method to improve survival will be more effective systemic therapy

Signet ring cell carcinomas

  • Usually high-grade, high-stage tumors at presentation
  • Poor prognosis

Sarcoma

  • Subclassification of sarcoma is based on histologic variations, depending on the specific malignant cell type
  • Leiomyosarcoma is the most common histologic subtype, followed by rhabdomyosarcoma and then, rarely, angiosarcoma, osteosarcoma, and carcinosarcoma

Questions

Answers

References

  • Wein AJ, Kavoussi LR, Partin AW, Peters CA (eds): CAMPBELL-WALSH UROLOGY, ed 11. Philadelphia, Elsevier, 2015, chap 92